Research Article
Economic costs of anxiety disorders
Article first published online: 7 DEC 1998
DOI: 10.1002/(SICI)1522-7154(1996)2:4<167::AID-ANXI2>3.0.CO;2-L
Copyright © 1996 Wiley-Liss, Inc.
1522-7154/asset/cover.gif?v=1&s=3a16f982ae2add4594f040ef473ef188f314ae4d "Anxiety")
Additional Information
How to Cite
DuPont, R. L., Rice, D. P., Miller, L. S., Shiraki, S. S., Rowland, C. R. and Harwood, H. J. (1996), Economic costs of anxiety disorders. Anxiety, 2: 167–172. doi: 10.1002/(SICI)1522-7154(1996)2:4<167::AID-ANXI2>3.0.CO;2-L
Publication History
- Issue published online: 7 DEC 1998
- Article first published online: 7 DEC 1998
- Manuscript Accepted: 5 JAN 1996
- Manuscript Revised: 15 DEC 1995
- Manuscript Received: 5 MAY 1995
- Abstract
- References
- Cited By
Keywords:
- anxiety disorders;
- cost and cost analysis;
- economics;
- mental health services;
- policy-making
Abstract
Anxiety disorders are estimated to affect 26.9 million individuals in the United States at some point during their lives. This study used the human capital approach to estimate the direct and indirect costs of these highly prevalent disorders. In 1990, costs associated with anxiety disorders were $46.6 billion, 31.5% of total expenditures for mental illness. Less than one-quarter of costs associated with anxiety disorders were for direct medical treatment; over three-quarters were attributable to lost or reduced productivity. Most of these indirect costs were associated with morbidity, as mortality accounted for just 2.7% of the total. Greater availability of effective, relatively low-cost outpatient treatment could substantially reduce the economic and social burden of these common and often crippling disorders. Anxiety 2:167–172 (1996). © 1996 Wiley-Liss, Inc.